Personalized, autologous neoantigen-specific T cell therapy in metastatic melanoma: a phase 1 trial
2025 · Nature Medicine · 33 citations
https://doi.org/10.1038/s41591-024-03418-4
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
22
Papers
1.1K
Citations
7
h-index
6
i10-index
Kristen N. Balogh is an academic researcher from BioNTech (United States). The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Immunotherapy and Immune Responses & CAR-T cell therapy research. The author has an h-index of 7, co-authored 19 publications.
ORCID: 0000-0002-8746-745XClick to start Chat